| Literature DB >> 21569567 |
Julia Garbe1, Boyke Bunk, Manfred Rohde, Max Schobert.
Abstract
BACKGROUND: Phages could be an important alternative to antibiotics, especially for treatment of multiresistant bacteria as e.g. Pseudomonas aeruginosa. For an effective use of bacteriophages as antimicrobial agents, it is important to understand phage biology but also genes of the bacterial host essential for phage infection.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21569567 PMCID: PMC3120641 DOI: 10.1186/1471-2180-11-102
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Morphology of phage JG004. Electron microscopic image of negatively stained phage JG004, which exhibits a contractile sheath and a central tube with a length of 115 nm and a hexagonal head structure with a diameter of 67 nm.
Strains and phages used in this study.
| Bacterial strain or phage | Phenotype or genotype | Reference |
|---|---|---|
| PAO1* | Wild type | [ |
| PA14 | Wild type | [ |
| PAO1 Δ | PAO1 | Sabrina Thoma, this laboratory, unpublished |
| PAO1 Δ | [ | |
| PAO1 Δ | [ | |
| PAO1 Δ | Julia Garbe, this laboratory, unpublished | |
| BT2, BT72, BT73, RN3, RN43, RN45*, NN84 | Clinical CF isolates | Medical Highschool Hannover, Germany |
| PACF15, PACF21*, PAKL1, | Clinical CF isolates | Gerd Döring, |
| PAKL4*, PACF60*, PACF61*, PACF62, PACF63* | Tübingen, Germany | |
| Nr. 18*, 19*, 26*, 29 | Urinary tract infection isolate | Michael Hogardt, München, Germany |
| JG004 | Wild type PAO1 LPS-specific lytic bacteriophage | This study |
* = strains infected by phage JG004 in the host range and receptor studies.
Abbreviations: GmR, resistant to gentamicin; TcR, resistant to tetracyclin; eGFP, enhanced green fluorescent protein; LPS, lipopolysaccharide.
Figure 2Growth of JG004. One step growth curve of phage JG004. A representative growth experiment of three independent experiments is shown. Within 34 min, the phage is able to produce about 13 phage progeny per infected cell.
General features of the JG004 genome
| Feature | Genome JG004 |
|---|---|
| Genome size | 93,017 bp |
| G+C content (G+C content host) | 49,26% (68%) |
| No. of predicted CDSs | 161 |
| Predicted tRNAs | tRNAGlu; tRNAPhe; tRNAGly; tRNAPro; tRNAAsn; tRNACys; tRNAAsp; tRNAIle; tRNALeu; tRNALys; tRNAArg; tRNAGln |
| % of genome with non-coding regions | 11.3% |
Predicted Terminator sequences.
| Position | Gene | Sequence | Strand | Score |
|---|---|---|---|---|
| 1682 - 1711 | gene 3 | plus | 100 | |
| 1711 - 1682 | gene 4 | minus | 93 | |
| 5477 - 5462 | gene 12 | plus | 100 | |
| 14969 - 14951 | gene 30 | minus | 95 | |
| 31234 - 31251 | gene 64 | plus | 93 | |
| 35839 - 35864 | gene 71 | plus | 95 | |
| 51300 - 51330 | gene 91 | plus | 100 | |
| 51328 - 51302 | gene 92 | minus | 95 | |
| 51302 - 51328 | gene 91 | plus | 100 | |
| 66578 - 66593 | gene 116 | plus | 100 | |
| 72492 - 72507 | gene 129 | plus | 93 | |
| 76657 - 76683 | gene 133 | plus | 95 | |
| 79632 - 79650 | gene 142 | plus | 100 | |
| 80739 - 80756 | gene 143 | plus | 100 | |
| 87753 - 87785 | gene 162 | plus | 100 | |
| 92215 - 92198 | gene 173 | minus | 93 | |
Terminator sequences are shown as displayed by TransTermHP. Each terminator sequence starts with 15 nt of the 5' tail (underlined) followed by the 5' stem, loop, 3' stem and 15 nt of the 3' tail (underlined). Score as provided by TransTermHP, only terminators with a score above 90 are shown.
Figure 3Genome of JG004. Schematic representation of the JG004 genome with its assumed tRNAs, genes and some functional assignments. The arrowheads point in the direction of transcription. Gene 46-57 represent the tRNAs of phage JG004. Predicted terminator structures are indicated as hairloop structures.
Transposon mutants screened with the LPS specific phage JG004.
| Transposon mutant | Integration of transposon | Product name* | Pathway and Literature |
|---|---|---|---|
| TM3 | S-adenosylmethionine decarboxylase proenzyme | Polyamine biosynthesis (PseudoCyc) | |
| TM4 | PA0534 | conserved hypothetical protein | - |
| TM7 | PA0421 | hypothetical protein | - |
| TM12 | hypothetical protein | Involved in O-antigen chain length determination/LPS biosynthesis [ | |
| TM13 | PA2555 | probable AMP-binding enzyme | - |
| TM15 | phosphomannomutase | LPS biosynthesis; alginate biosynthesis [ | |
| TM16 | alpha-1,6-rhamnosyl-transferase | LPS outer core biosynthesis [ | |
| TM17 | glucose-1-phosphate thymidylyltransferase | LPS biosynthesis [ | |
| TM18 | O-antigen ligase | LPS biosynthesis [ | |
| TM19 | PA5001 | hypothetical protein | LPS biosynthesis [ |
| TM20, TM22 | dTDP-D-glucose 4,6-dehydratase | LPS biosynthesis [ | |
| TM21 | PA2200 | conserved hypothetical protein | - |
| TM23 | alpha-1,3-rhamnosyl-transferase WapR | LPS outer core biosynthesis [ | |
Integration of the transposon was identified by arbitrary PCR.* = according to http://www.pseudomonas.com
Figure 4LPS profile of transposon mutants. Silver stained SDS-PAGE illustrating the isolated LPS of the wild type PAO1 and the transposon mutants. Only the gene, interrupted by the transposon of the respective mutant is indicated on top of the lanes, PAO1 is the P. aeruginosa wild type. The arrow points to the black line in the lower part of the gel. This line indicates the migration of wild type lipid A and core sugars of the LPS [42]. As indicated, the LPS of the speD, PA0534, PA0421, PA2555 and migA mutant strains appears similar to wild type LPS. The LPS profile of the remaining mutant strains is different and indicates an altered LPS structure. Interestingly, the biochemical analysis of LPS indicates that gene PA2200 might be involved in biosynthesis or modification of P. aeruginosa LPS due to altered migration.